Insmed shares rocketed on results for a pulmonary arterial hypertension drug that exceeded Wall Street expectations.

Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...

Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...

Diana Moser has, to the best of her knowledge, not contracted Lyme disease, a welcome status quo that might be credited to ...

Your bedtime screen time is not just delaying your sleep, it’s ruining your sleep cycle and mental health. And if you think ...

Duavee, approved for menopause, may help prevent invasive breast cancer by slowing cell growth in breast cancer, offering a ...

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...

Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 9:20 PM ETCompany ParticipantsJames E.

DelveInsight's Alzheimer's Disease Pipeline report depicts a robust space with 200+ active players working to develop 220+ ...

Evogene Ltd. has unveiled a first-in-class generative AI foundation model for small-molecule design, marking a breakthrough ...

In a world where celebrities dominate headlines and social media feeds, one event stands apart by turning the spotlight on an ...